BOSTON, March 10, 2025 (GLOBE NEWSWIRE) — Psy Therapeutics, based in Boston, MA, focused on discovering and developing treatments for neuropsychiatric and neurodegenerative disorders, today announced that David Barlow, Chair & CEO, and Alan Cross, CSO, will present live at the Virtual Life Science Investor Forum hosted by VirtualInvestorConferences.com, on March 13th, 2025.
DATE: March 13th
TIME: 11:00 AM EDT
LINK: https://bit.ly/4iAq0O7
Available for 1×1 meetings: March 13th, 14th, 17th and 18th
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Recent Company Highlights
- PSY-05: Oral, potential first-in-class treatment …
